Stroke ranks among the leading causes of disability globally.
According to the World Health Organization (WHO), over 17 million people worldwide experience a stroke each year, and the recovery of function after a stroke is a crucial aspect of rehabilitation.
That’s why there is an urgent need to research and introduce new effective medications to the market that can assist individuals in overcoming the consequences of a stroke and other traumatic conditions requiring rehabilitation.
On the basis of ClinicalTrialsUA, trials were conducted for medications intended for the treatment or supportive therapy of diseases and conditions requiring rehabilitation.
As a result, these medications have demonstrated significant effectiveness in rehabilitating post-traumatic conditions, reducing pain syndromes in individuals with burns and fractures.
On the basis of ClinicalTrialsUA a range of tools, technologies, and equipment are employed to assess the effectiveness and safety of new treatment methods and approaches.
ClinicalTrialsUA employs various tools, including electrical stimulation devices, magnetic therapy, ultrasound devices, and others, for physical therapy procedures.
This encompasses prostheses, orthoses, sensors, trackers, electronic medical records, and biomarkers.
ClinicalTrialsUA conducts high-quality clinical researches utilizing state-of-the-art technologies and equipment.
This approach guarantees the high quality of data and the relevance of results for potential clients.
Our brand is built on extensive experience and trust. Our team comprises only highly qualified researchers and specialists with expertise in clinical protocols.
